Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes ...

WEIGHTWATCHERS CEO SIMA SISTANI OUT IN ABRUPT EXIT, EMBRACED WEIGHT LOSS DRUGS The company, which has seen a significant boost in profits from Zepbound and Mounjaro ... 5 mg, or 15 mg per 0.5 mL ...

The company, which has seen a significant boost in profits from Zepbound and Mounjaro – essentially ... 10 mg, 12.5 mg, or 15 mg per 0.5 mL doses in a single-dose pen.

A 5 mg vial of the once-weekly drug has been priced at Rs 4,375, while a 2.5 mg vial will cost Rs 3,500. Mounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the ...

Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and 3,500 ... The company's shares were down 0.6% at 1145 GMT ...